Recent developments for Staphylococcus aureus vaccines: Clinical and basic science challenges

European Cells and Materials

Volumn 30, Issue , 2015, Pages 315-326

  Proctor, Richard ^a  

^a Division of Gynecologic Oncology   (United States)

Author keywords

Clinical trials; Immunity; Staphylococcus aureus; Th17; Vaccine

Indexed keywords

BIOLOGICAL MARKER; STAPHYLOCOCCUS VACCINE; VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; NONHUMAN; PASSIVE IMMUNIZATION; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION; ANIMAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; MICROBIOLOGY; RESEARCH; STAPHYLOCOCCUS AUREUS; TRENDS;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; RESEARCH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VACCINES;

EID: 84951134434     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v030a22     Document Type: Article

References (109)

1. Allen KB, Fowler VG Jr, Gammie JS, Hartzel JS, Onorato MT, DiNubile MJ, Sobanjo-Ter Meulen A (2014) Staphylococcus aureus infections after elective cardiothoracic surgery: observations from an international randomized placebo-controlled trial of an Investigational S. aureus vaccine. Open Forum Infect Dis 1: doi: 10.1093/ ofid/ofu071.
2. Aman MJ, Adhikari RP (2014) Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy. Toxins (Basel) 6: 950-972.
3. Bebbington C, Yarranton G (2008) Antibodies for the treatment of bacterial infections: current experience and future prospects. Curr Opin Biotechnol 19: 613-619.
4. Bestebroer J, De Haas CJ, Van Strijp JA (2010) How microorganisms avoid phagocyte attraction. FEMS Microbiol Rev 34: 395-414.
5. Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, Burns DL (2013) Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection. PLoS One 8: e63040.
6. Braum O, Pirzer H, Fickenscher H (2012) Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells. Antiinflamm Antiallergy. Agents Med Chem 11: 221-229.
7. Casillas-Ituarte NN, Lower BH, Lamlertthon S, Fowler VG Jr, Lower SK (2012) Dissociation rate constants of human fibronectin binding to fibronectin-binding proteins on living Staphylococcus aureus isolated from clinical patients. J Biol Chem 287: 6693-6701.
8. Castanet J, Lacour JP, Perrin C, Brun P, Ortonne JP (1994) Juvenile pityriasis rubra pilaris associated with hypogammaglobulinaemia and furunculosis. Br J Dermatol 131: 717-719.
9. Chen AF, Wessel CB, Rao N (2013) Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res 471: 2383-2299.
10. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, Magorien JE, Blauvelt A, Kolls JK, Cheung AL, Cheng G, Modlin RL, Miller LS (2010) IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 120: 1762-1773.
11. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong C (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
12. Colling K, Statz C, Glover J, Banton K, Beilman G (2015) Pre-operative antiseptic shower and bath policy decreases the rate of S. aureus and methicillin-resistant S. aureus surgical site infections in patients undergoing joint arthroplasty. Surg Infect (Larchmt) 16: 124-132.
13. Crum-Cianflone N, Weekes J, Bavaro M (2009) Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS 23: 499-502.
14. David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23: 616-687.
15. DeJonge M, Burchfield D, Bloom B, Duenas M, Walker W, Polak M, Jung E, Millard D, Schelonka R, Eyal F, Morris A, Kapik B, Roberson D, Kesler K, Patti J, Hetherington S (2007) Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 151: 260-265.
16. Donabedian H, Gallin J I (1983) The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore) 62: 195-208.
17. Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH (2010) Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 185: 1711-1719.
18. Elek SD, Conen PE (1957) The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 38: 573-586.
19. Farrell DJ, Robbins M, Rhys-Williams W, Love WG (2010) In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Int J Antimicrob Agents 35: 531-536.
20. Farrell DJ, Robbins M, Rhys-Williams W, Love WG (2011) Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study. Antimicrob Agents Chemother 55: 1177-1181.
21. Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D (2015) Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study. Hum Vaccin Immunother 11: 632-641.
22. Fisher A, Webber BJ, Pawlak MT, Johnston L, Tchandja JB, Yun H (2015) Epidemiology, microbiology, and antibiotic susceptibility patterns of skin and soft tissue infections, Joint Base San Antonio-Lackland, Texas, 2012- 2014. MSMR 22: 2-6.
23. Foster TJ, Geoghegan JA, Ganesh VK, Höök M (2014) Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol 12: 49-62.
24. Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW, Corey GR, Carmeli Y, Betts R, Hartzel JS, Chan IS, McNeely TB, Kartsonis NA, Guris D, Onorato MT, Smugar SS, DiNubile MJ, Sobanjo-ter Meulen A (2013) Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 309: 1368-1378.
25. Fowler VG Jr, Proctor RA (2014) Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect 20 Suppl 5: 66-75.
26. Fritz SA, Tiemann KM, Hogan PG, Epplin EK, Rodriguez M, Al-Zubeidi DN, Bubeck Wardenburg J, Hunstad DA (2013) A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin Infect Dis 56: 1554-1561.
27. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R (2013) Targeted versus universal decolonization to prevent ICU infection. CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare- Associated Infections Program. New Engl J Med 368: 2255-2265.
28. Ishigame H, Kakuta S, Nagai T Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119.
29. Jansen KU, Girgenti DQ, Scully IL, Anderson AS (2013) Vaccine review: Staphylococcus aureus vaccines: problems and prospects. Vaccine 31: 2723-2230.
30. Joshi A, Pancari G, Cope L, Bowman EP, Cua D, Proctor RA, McNeely T (2012) Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum Vaccin Immunother 8: 336-346.
31. Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA (2015) Periprosthetic joint infection. Lancet, doi: 10.1016/S0140-6736(14)61798-0.
32. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC (2010) Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am 92: 1820-1826.
33. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
34. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, Kristosturyan E, Whitney AR, Sturdevant DE, Dorward DW, Holland SM, Kreiswirth BN, Musser JM, DeLeo FR (2010) Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2: 560-575.
35. Kolata JB, Kühbandner I, Link C, Normann N, Vu CH, Steil L, Weidenmaier C, Bröker BM (2015) The fall of a dogma? Unexpected high T-cell memory response to Staphylococcus aureus in humans. J Infect Dis 212: 830- 838.
36. Laabei M, Uhlemann AC, Lowy FD, Austin ED, Yokoyama M, Ouadi K, Feil E, Thorpe HA, Williams B, Perkins M, Peacock SJ, Clarke SR, Dordel J, Holden M, Votintseva AA, Bowden R, Crook DW, Young BC, Wilson DJ, Recker M, Massey RC (2015) Evolutionary trade-offs underlie the multi-faceted virulence of Staphylococcus aureus. PLoS Biol 13: e1002229.
37. Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter (2012) Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 30: 544-551.
38. Lee H, Lim H, Bae IK, Yong D, Jeong SH, Lee K, Chong Y (2013) Coexistence of mupirocin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates from Korea. Diagn Microbiol Infect Dis 75: 308- 312.
39. Li L, Kim J, Boussiotis VA (2010) IL-1 beta-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells. J Immunol 185: 4148-4153.
40. Lin WT, Wu CD, Cheng SC, Chiu CC, Tseng CC, Chan HT, Chen PY, Chao CM (2015) High prevalence of methicillin-resistant Staphylococcus aureus among patients with septic arthritis caused by Staphylococcus aureus. PLoS One 10: e0127150.
41. Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, Fu Y, French SW, Edwards JE Jr, Spellberg B (2009) Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5: e1000703.
42. Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS, Enright MC, O'Hanlon SJ, Thomas JC, Perdreau-Remington F, Gordon S, Gunthorpe H, Jacobs R, Jensen P, Leoung G, Rumack JS, Chambers HF (2008) A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 46: 1637-1646.
43. Lower SK, Lamlertthon S, Casillas-Ituarte NN, Lins RD, Yongsunthon R, Taylor ES, DiBartola AC, Edmonson C, McIntyre LM, Reller LB, Que YA, Ros R, Lower BH, Fowler VG Jr (2011) Polymorphisms in fibronectin binding protein A of Staphylococcus aureus are associated with infection of cardiovascular devices. Proc Natl Acad Sci U S A 108: 18372-18377.
44. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
45. Lu T, Porter AR, Kennedy AD, Kobayashi SD, DeLeo FR (2014) Phagocytosis and killing of Staphylococcus aureus by human neutrophils. J Innate Immun 6: 639-649.
46. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205: 1551-1557.
47. Maródi L, Cypowyj S, Tóth B, Chernyshova L, Puel A, Casanova JL (2012) Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J Allergy Clin Immunol 130: 1019-1027.
48. Marwaha AK, Leung NJ, McMurchy AN, Levings MK (2012) Th17 cells in autoimmunity and immunodeficiency: Protective or Pathogenic? Front Immunol 3: 1-8.
49. McCarthy H, Rudkin JK, Black NS, Gallagher L, O'Neill E, O'Gara JP (2015) Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol 5: 1. doi: 10.3389/fcimb.2015.00001
50. McDanel JS, Murphy CR, Diekema DJ, Quan V, Kim DS, Peterson EM, Evans KD, Tan GL, Hayden MK, Huang SS (2013) Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother 57: 552-558.
51. McGirr A, Fisman DN (2015) Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics 135: 331-343.
52. McNeely TB, Shah NA, Fridman A, Joshi A, Hartzel JS, Keshari RS, Lupu F, DiNubile MJ (2014) Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors. Hum Vaccin Immunother 10: 3513-3516.
53. McNeil JC, Hulten KG, Kaplan SL, Mason EO (2014) Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother 58: 2878-2883.
54. Mehta S, Hadley S, Hutzler L, Slover J, Phillips M, Bosco JA 3rd. Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden (2013) Clin Orthop Relat Res 471: 2367-2371. (see erratum in Clin Orthop Relat Res 471: 2044, 2013)
55. Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, Conrad C, Gregorio J, Le Roy D, Roger T, Ladbury JE, Homey B, Watowich S, Modlin, RL Kontoyiannis DP, Liu YJ, Arold ST, Gilliet M (2015) TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nat Immunol 16: 970-979.
56. Millar EV, O'Brien KL, Watt JP, Lingappa J, Pallipamu R, Rosenstein N, Hu D, Reid R, Santosham M (2005) Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003. Clin Infect Dis 40: 823-830.
57. Miller MA, Dascal A, Portnoy J, Mendelson J (1996) Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17: 811-813.
58. Minegishi Y, Saito M, Nagasawa M Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, Tsuge I, Karasuyama H (2009) Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 206: 1291-1301.
59. Misstear K, McNeela EA, Murphy AG, Geoghegan JA, O'Keeffe KM, Fox J, Chan K, Heuking S, Collin N, Foster TJ, McLoughlin RM, Lavelle EC (2014) Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus. J Infect Dis 209: 1479- 1484.
60. Montgomery CP, Daniels M, Zhao F, Alegre ML, Chong AS, Daum RS (2014) Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect Immun 82: 2125- 2134.
61. Montgomery CP, David MZ, Daum RS (2015) Host factors that contribute to recurrent staphylococcal skin infection. Curr Opin Infect Dis 28: 253-258.
62. Montanaro L, Speziale P, Campoccia D, Ravaioli S, Cangini I, Pietrocola G, Giannini S, Arciola CR (2011) Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol 6: 1329-1349.
63. Morrison-Rodriguez SM, Pacha LA, Patrick JE, Jordan NN (2010) Community-associated methicillin-resistant Staphylococcus aureus infections at an army training installation. Epidemiol Infect 138: 721-729.
64. Narita K, Hu DL, Mori F, Wakabayashi K, Iwakura Y, Nakane A (2010) Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Infect Immun 78: 4234-4242.
65. Nissen M, Marshall H, Richmond P, Shakib S, Jiang Q, Cooper D, Rill D, Baber J, Eiden J, Gruber W, Jansen KU, Emini EA, Anderson AS, Zito ET, Girgenti D (2015) A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. Vaccine 33: 1846-1854.
66. O'Keeffe KM, Wilk MM, Leech JM, Murphy AG, Laabei M, Monk IR, Massey RC, Lindsay JA, Foster TJ, Geoghegan JA, McLoughlin RM (2015) Manipulation of autophagy in phagocytes facilitates Staphylococcus aureus bloodstream infection. Infect Immun 83: 3445-3457.
67. Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, Grimnes G, Jorde R, Simonsen GS, Furberg AS (2012) Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study. Eur J Clin Microbiol Infect Dis 31: 465-473.
68. Pancari G, Fan H, Smith S, Joshi A, Haimbach R, Clark D, Li Y, Hua J, McKelvey T, Ou Y, Drummond J, Cope L, Montgomery D, McNeely T (2012) Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB). Front Cell Infect Microbiol 20:36. eCollection 2012.
69. Parvizi J, Alijanipour P, Barberi EF, Hickok NJ, Phillips KS, Shapiro IM, Schwarz EM, Stevens MH, Wang Y, Shirtliff ME (2015) Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections. J Am Acad Orthop Surg 23 Suppl: S32-S43.
70. Pauli NT, Kim HK, Falugi F, Huang M, Dulac J, Henry Dunand C, Zheng NY, Kaur K, Andrews SF, Huang Y, DeDent A, Frank KM, Charnot-Katsikas A, Schneewind O, Wilson PC (2014) Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J Exp Med 211: 2331-2339.
71. Pozzi C, Lofano G, Mancini F, Soldaini E, Speziale P, De Gregorio E, Rappuoli R, Bertholet S, Grandi G, Bagnoli F (2015) Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus. FEMS Microbiol Rev 39: 750-763.
72. Proctor RA (2012a) Is there a future for a Staphylococcus aureus vaccine? Vaccine 30: 2921-2927.
73. Proctor RA (2012b) Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 54: 1179- 1186.
74. Provenza G, Provenzano M, Visai L, Burke FM, Geoghegan JA, Stravalaci M, Gobbi M, Mazzini G, Arciola CR, Foster TJ, Speziale P (2010) Functional analysis of a murine monoclonal antibody against the repetitive region of the fibronectin-binding adhesins fibronectin-binding protein A and fibronectin-binding protein B from Staphylococcus aureus. FEBS J 277: 4490-4505.
75. Puel A, Picard C, Lorrot M, Pons C, Chrabieh M, Lorenzo L, Mamani-Matsuda M, Jouanguy E, Gendrel D, Casanova JL (2008) Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol 180: 647-654.
76. Quilty S, Kwok G, Hajkowicz K, Currie B (2009) High incidence of methicillin-resistant Staphylococcus aureus sepsis and death in patients with febrile neutropenia at Royal Darwin Hospital. Intern Med J 39: 557-559.
77. Rasigade JP, Sicot N, Laurent F, Lina G, Vandenesch F, Etienne J (2011) A history of Panton-Valentine leukocidin (PVL)-associated infection protects against death in PVL-associated pneumonia. Vaccine 29: 4185-4186.
78. Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G (2012) Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis 206: 1604-1611.
79. Ross CL, Liang X, Liu Q, Murray BE, Höök M, Ganesh VK (2012) Targeted protein engineering provides insights into binding mechanism and affinities of bacterial collagen adhesins. J Biol Chem 287: 34856-34865.
80. Rupp ME, Holley HP, Jr, Lutz J, Dicpinigaitis PV, Woods CW, Levine DP, Veney N, Fowler VG, Jr (2007) Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 51: 4249-4254.
81. Salgado-Pabón W, Schlievert PM (2014) Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol 12: 585-591.
82. Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE Jr, Hennessey JP Jr (2012) NDV- 3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30: 7594-7600.
83. Schreiner J, Kretschmer D, Klenk J, Otto M, Bühring HJ, Stevanovic S, Wang JM, Beer-Hammer S, Peschel A, Autenrieth SE (2013) Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol 190: 3417-3426.
84. Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, Braun B, Herwaldt L (2013) Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 346: doi: 10.1136/bmj. f2743.
85. Seah C, Alexander DC, Louie L, Simor A, Low DE, Longtin J, Melano RG (2012) MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. Antimicrob Agents Chemother 56: 1916-1920.
86. Seok, J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG; Inflammation and Host Response to injury, Large Scale Collaborative Research Program (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110: 3507-3512.
87. Serruto D, Rappuoli R, Scarselli M, Gros P, van Strijp JA (2010) Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol 8: 393-399.
88. Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R (2002) Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346: 491-496.
89. Shvili D, David M, Mimouni M (1987) Childhood onset pityriasis rubra pilaris with immunologic abnormalities. Pediatr Dermatol 4: 21-23.
90. Smigiel KS, Srivastava S, Stolley JM, Campbell DJ (2014) Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation. Immunol Rev 259: 40-59.
91. Spaan AN, Surewaard BG, Nijland R, van Strijp JA (2013) Neutrophils versus Staphylococcus aureus: A biological tug of war. Annu Rev Microbiol 67: 629-650.
92. Spaulding AR, Lin YC, Merriman JA, Brosnahan AJ, Peterson ML, Schlievert PM (2012) Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine 30: 5099-5109.
93. Spellberg B, Ibrahim AS, Yeaman MR, Lin L, Fu Y, Avanesian V, Bayer AS, Filler SG, Lipke P, Otoo H, Edwards JE Jr (2008) The antifungal vaccine derived from the recombinant N terminus of Als3 protects mice against the bacterium Staphylococcus aureus. Infect Immun 76: 4574-4580.
94. Tkaczyk C, Hua L, Varkey R, Shi Y, Dettinger L, Woods R, Barnes A, MacGill RS, Wilson S, Chowdhury P, Stover CK, Sellman BR (2012) Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin Vaccine Immunol 19: 377-385.
95. Thomason J, Rentsch C, Stenehjem EA, Hidron AI, Rimland D (2015) Association between vitamin D deficiency and methicillin-resistant Staphylococcus aureus infection. Infection, 43: 715-722.
96. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28: 603-661.
97. Van der Does AM, Kenne E, Koppelaar E, Agerberth B, Lindbom L (2014) Vitamin D3 and phenylbutyrate promote development of a human dendritic cell subset displaying enhanced antimicrobial properties. J Leukoc Biol 95: 883- 891.
98. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frölich M (1998) Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950-953.
99. van Kessel KP, Bestebroer J, van Strijp JA (2014) Neutrophil-Mediated Phagocytosis of Staphylococcus aureus. Front Immunol 5: 467.
100. Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, Nishitani K, Mack S, Hunter JG, Kates SL, Daiss JL, Schwarz EM (2014) Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters. J Orthop Res 32: 1389-1396.
101. Verkaik NJ, Lebon A, de Vogel CP, Hooijkaas H, Verbrugh HA, Jaddoe VW, Hofman A, Moll HA, van Belkum A, van Wamel WJ (2010) Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect 16: 1312-1317.
102. Vivoni AM, Santos KR, de-Oliveira MP, Giambiagi-deMarval M, Ferreira AL, Riley LW, Moreira BM (2005) Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp Epidemiol 26: 662-667.
103. Walker ES, Vasquez JE, Dula R, Bullock H, Sarubbi FA (2003) Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect Control Hosp Epidemiol 24: 342-346.
104. Wang JW, Hogan PG, Hunstad DA, Fritz SA (2015) Vitamin D sufficiency and Staphylococcus aureus infection in children. Pediatr Infect Dis J 34: 544-555.
105. Weems J, Steinberg J, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG Jr (2006) Veronate human polyclonal IgG with high anti-S. aureus and anti-polyclonal antibodies tested in neonates. Antimicrob Agents Chemother 50: 2751-2755.
106. White CJ, Gallin JI (1986) Phagocyte defects. Clin Immunol Immunopathol 40: 50-61.
107. Yan L, Zhang L, Ma H, Chiu D, Bryers JD (2014) A single B-repeat of Staphylococcus epidermidis accumulation-associated protein induces protective immune responses in an experimental biomaterial-associated infection mouse model. Clin Vaccine Immunol 21: 1206-1214.
108. Clinical Trials. Gov: https://clinicaltrials.gov/ct2/results? term=staphylococcus&Search=Search
109. GSK Pipeline Report, March 2015: http://www.gsk.com/ en-gb/research/what-we-are-working-on/product-pipeline/